FDA Import Refusal AEK-7449863-3/40002/1 — GLAXO SMITHKLINE LTD
The FDA refused shipment AEK-7449863-3/40002/1 from GLAXO SMITHKLINE LTD (India) on Sep 24, 2025. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 24, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XDY45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
- Charges
- 75